CDC’s Investments to Combat Antibiotic Resistance Threats: Texas: Fiscal Year 2020

Details

• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.)
• Description:
  Funding for AR Activities Fiscal Year 2020: $1,967,740
  
  1 local CDC fellow
  
  Publication date from document properties.
  
  Texas-CDC-AR-Investments.pdf
  
  
• Series:
  Antibiotic Resistance (AR) Solutions in Action
• Document Type:
  Text
• Name as Subject:
  Antimicrobial Stewardship ; Carbapenem-Resistant Enterobacteriaceae ; Communicable Diseases, Emerging ; Cross Infection/prevention & control ; Drug Resistance, Microbial ; Financing, Government ; Food Safety ; Gonorrhea/prevention & control ; Local Government ; Public Health ; State Government ; Antimicrobial Stewardship ; Carbapenem-Resistant Enterobacteriaceae ; Communicable Diseases, Emerging ; Cross Infection/prevention & control ; Drug Resistance, Microbial ; Financing, Government ; Food Safety ; Gonorrhea/prevention & control ; Local Government ; Public Health ; State Government
• Genre:
  Pamphlet (or booklet)
• Place as Subject:
  Texas
• Federal Fiscal Year:
  2020
• Collection(s):
  Stephen B. Thacker CDC Library
• Main Document Checksum:
  urn:sha-512:4c21dbd8626d25943c19da09254eefd4eaf9806fd1382fc97d4fd679ecb866f6c39a216cbc8ec96976626eb8d507255f9db01a99f18c6f44290f5040888d5212
• Download URL:
  https://stacks.cdc.gov/view/cdc/102803/cdc_102803_DS1.pdf
• File Type:
  [PDF - 370.47 KB ]